Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165412 · ClinicalTrials.gov registry record
Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 148
- Enrollment target
NCT00165412: Completed study, sponsored by Dana-Farber Cancer Institute.
NCT00165412 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00165412 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.
Interventions
- PROCEDURE Mammogram
- PROCEDURE breast MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2005-07 |
| Est. Completion | 2010-05 |
What the finished NCT00165412 record still lists
NCT00165412 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Mammogram is the first listed.
NCT00165412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00165412 about?
NCT00165412 is a clinical study titled "Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease". The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.
What is the current status of trial NCT00165412?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2005-07. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00165412?
The interventions under investigation include: Mammogram (PROCEDURE), breast MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00165412?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia